Healthcare giant Johnson & Johnson (NYSE:JNJ) reported its first-quarter results on April 20, 2021.In this Motley Fool Live video, recorded on April 21, Motley Fool contributors Keith Speights and Brian Orelli discuss how J&J performed and which of the company's segments was the biggest winner in Q1.
Keith Speights: The big results for this week were from the biggest healthcare company on the planet, Johnson & Johnson. J&J announced their Q1 results. Brian, what do you think are the highlights from this update that investors should really pay attention to?
Brian Orelli: Sales were up 7.9 percent. Some of that was due to the stronger dollar. Operationally, sales were up 5.5 percent. Consumer Health was down year over year. That's not too surprising since there was a lot of stocking up in the year-ago quarter as the pandemic started happening, so that was understandable. Pharmaceuticals were up 9.6 percent and medical devices were up 10.9 percent. Adjusted earnings per share were up 12.6 percent, so Johnson & Johnson is doing as it always does and growing earnings faster than revenue, which is we'd like to see that continuing.